APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurovascular Interventional Devices

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Neurovascular Interventional Devices Market Analysis and Forecast 2026-2032

5 July 2026194 pages

Choose your research edition.

Industry ResearchNeurovascular Interventional Devices Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurovascular Interventional Devices Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Neurovascular Interventional Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurovascular Interventional Devices Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurovascular Interventional Devices Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Neurovascular Interventional Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Neurovascular Interventional Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neurovascular Interventional Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Neurovascular Interventional Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neurovascular Interventional Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Neurovascular Interventional Devices include Johnson & Johnson, Medtronic PLC, W.L. Gore & Associates, Terumo Corporation, Stryker Corporation, Penumbra, Inc., Microport Scientific Corporation, Merit Medical Systems, Inc. and Cardinal Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Neurovascular Interventional Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neurovascular Interventional Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Neurovascular Interventional Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurovascular Interventional Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neurovascular Interventional Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Neurovascular Interventional Devices sales, projected growth trends, production technology, application and end-user industry.

Neurovascular Interventional Devices Segment by Company

Johnson & Johnson

Medtronic PLC

W.L. Gore & Associates

Terumo Corporation

Stryker Corporation

Penumbra, Inc.

Microport Scientific Corporation

Merit Medical Systems, Inc.

Cardinal Health

Boston Scientific Corporation

Abbott Laboratories

Neurovascular Interventional Devices Segment by Type

Embolization Coils

Intrasaccular Devices

Intracranial Stents

Carotid Stents

Flow Diverters

Others

Neurovascular Interventional Devices Segment by Application

Ambulatory Surgical Centers

Hospitals

Clinics

Others

Neurovascular Interventional Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurovascular Interventional Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurovascular Interventional Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurovascular Interventional Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Neurovascular Interventional Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Neurovascular Interventional Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurovascular Interventional Devices sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neurovascular Interventional Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Embolization Coils Major Manufacturers Table 3. Intrasaccular Devices Major Manufacturers Table 4. Intracranial Stents Major Manufacturers Table 5. Carotid Stents Major Manufacturers Table 6. Flow Diverters Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Neurovascular Interventional Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Ambulatory Surgical Centers Major Manufacturers Table 10. Hospitals Major Manufacturers Table 11. Clinics Major Manufacturers Table 12. Others Major Manufacturers Table 13. Neurovascular Interventional Devices Industry Trends Table 14. Neurovascular Interventional Devices Industry Drivers Table 15. Neurovascular Interventional Devices Industry Opportunities and Challenges Table 16. Neurovascular Interventional Devices Industry Restraints Table 17. Global Neurovascular Interventional Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Neurovascular Interventional Devices Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Neurovascular Interventional Devices Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Neurovascular Interventional Devices Revenue Market Share by Region (2021-2026) Table 21. Global Neurovascular Interventional Devices Revenue Market Share by Region (2027-2032) Table 22. Global Neurovascular Interventional Devices Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 23. Global Neurovascular Interventional Devices Sales by Region (2021-2026) & (k units) Table 24. Global Neurovascular Interventional Devices Sales by Region (2027-2032) & (k units) Table 25. Global Neurovascular Interventional Devices Sales Market Share by Region (2021-2026) Table 26. Global Neurovascular Interventional Devices Sales Market Share by Region (2027-2032) Table 27. Global Neurovascular Interventional Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Neurovascular Interventional Devices Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Neurovascular Interventional Devices Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Neurovascular Interventional Devices Sales Market Share by Manufacturers (2021-2026) Table 31. Global Neurovascular Interventional Devices Sales Price (USD/unit) of Manufacturers (2021-2026) Table 32. Global Neurovascular Interventional Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Neurovascular Interventional Devices Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Neurovascular Interventional Devices Manufacturers, Product Type & Application Table 35. Global Neurovascular Interventional Devices Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Neurovascular Interventional Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Neurovascular Interventional Devices Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Neurovascular Interventional Devices Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Neurovascular Interventional Devices Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Neurovascular Interventional Devices Revenue Market Share by Type (2021-2026) Table 42. Global Neurovascular Interventional Devices Revenue Market Share by Type (2027-2032) Table 43. Global Neurovascular Interventional Devices Sales by Type 2021 VS 2025 VS 2032 (k units) Table 44. Global Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 45. Global Neurovascular Interventional Devices Sales by Type (2027-2032) & (k units) Table 46. Global Neurovascular Interventional Devices Sales Market Share by Type (2021-2026) Table 47. Global Neurovascular Interventional Devices Sales Market Share by Type (2027-2032) Table 48. Global Neurovascular Interventional Devices Price by Type (2021-2026) & (USD/unit) Table 49. Global Neurovascular Interventional Devices Price by Type (2027-2032) & (USD/unit) Table 50. Global Neurovascular Interventional Devices Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Neurovascular Interventional Devices Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Neurovascular Interventional Devices Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Neurovascular Interventional Devices Revenue Market Share by Application (2021-2026) Table 54. Global Neurovascular Interventional Devices Revenue Market Share by Application (2027-2032) Table 55. Global Neurovascular Interventional Devices Sales by Application 2021 VS 2025 VS 2032 (k units) Table 56. Global Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 57. Global Neurovascular Interventional Devices Sales by Application (2027-2032) & (k units) Table 58. Global Neurovascular Interventional Devices Sales Market Share by Application (2021-2026) Table 59. Global Neurovascular Interventional Devices Sales Market Share by Application (2027-2032) Table 60. Global Neurovascular Interventional Devices Price by Application (2021-2026) & (USD/unit) Table 61. Global Neurovascular Interventional Devices Price by Application (2027-2032) & (USD/unit) Table 62. Johnson & Johnson Company Information Table 63. Johnson & Johnson Business Overview Table 64. Johnson & Johnson Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 65. Johnson & Johnson Neurovascular Interventional Devices Product Portfolio Table 66. Johnson & Johnson Recent Development Table 67. Medtronic PLC Company Information Table 68. Medtronic PLC Business Overview Table 69. Medtronic PLC Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Medtronic PLC Neurovascular Interventional Devices Product Portfolio Table 71. Medtronic PLC Recent Development Table 72. W.L. Gore & Associates Company Information Table 73. W.L. Gore & Associates Business Overview Table 74. W.L. Gore & Associates Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. W.L. Gore & Associates Neurovascular Interventional Devices Product Portfolio Table 76. W.L. Gore & Associates Recent Development Table 77. Terumo Corporation Company Information Table 78. Terumo Corporation Business Overview Table 79. Terumo Corporation Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Terumo Corporation Neurovascular Interventional Devices Product Portfolio Table 81. Terumo Corporation Recent Development Table 82. Stryker Corporation Company Information Table 83. Stryker Corporation Business Overview Table 84. Stryker Corporation Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Stryker Corporation Neurovascular Interventional Devices Product Portfolio Table 86. Stryker Corporation Recent Development Table 87. Penumbra, Inc. Company Information Table 88. Penumbra, Inc. Business Overview Table 89. Penumbra, Inc. Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Penumbra, Inc. Neurovascular Interventional Devices Product Portfolio Table 91. Penumbra, Inc. Recent Development Table 92. Microport Scientific Corporation Company Information Table 93. Microport Scientific Corporation Business Overview Table 94. Microport Scientific Corporation Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Microport Scientific Corporation Neurovascular Interventional Devices Product Portfolio Table 96. Microport Scientific Corporation Recent Development Table 97. Merit Medical Systems, Inc. Company Information Table 98. Merit Medical Systems, Inc. Business Overview Table 99. Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Portfolio Table 101. Merit Medical Systems, Inc. Recent Development Table 102. Cardinal Health Company Information Table 103. Cardinal Health Business Overview Table 104. Cardinal Health Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Cardinal Health Neurovascular Interventional Devices Product Portfolio Table 106. Cardinal Health Recent Development Table 107. Boston Scientific Corporation Company Information Table 108. Boston Scientific Corporation Business Overview Table 109. Boston Scientific Corporation Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Boston Scientific Corporation Neurovascular Interventional Devices Product Portfolio Table 111. Boston Scientific Corporation Recent Development Table 112. Abbott Laboratories Company Information Table 113. Abbott Laboratories Business Overview Table 114. Abbott Laboratories Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Abbott Laboratories Neurovascular Interventional Devices Product Portfolio Table 116. Abbott Laboratories Recent Development Table 117. North America Neurovascular Interventional Devices Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Neurovascular Interventional Devices Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 120. North America Neurovascular Interventional Devices Sales by Type (2027-2032) & (k units) Table 121. North America Neurovascular Interventional Devices Sales Price by Type (2021-2026) & (USD/unit) Table 122. North America Neurovascular Interventional Devices Sales Price by Type (2027-2032) & (USD/unit) Table 123. North America Neurovascular Interventional Devices Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Neurovascular Interventional Devices Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 126. North America Neurovascular Interventional Devices Sales by Application (2027-2032) & (k units) Table 127. North America Neurovascular Interventional Devices Sales Price by Application (2021-2026) & (USD/unit) Table 128. North America Neurovascular Interventional Devices Sales Price by Application (2027-2032) & (USD/unit) Table 129. North America Neurovascular Interventional Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Neurovascular Interventional Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Neurovascular Interventional Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Neurovascular Interventional Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 133. North America Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 134. North America Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units) Table 135. North America Neurovascular Interventional Devices Sales Price by Country (2021-2026) & (USD/unit) Table 136. North America Neurovascular Interventional Devices Sales Price by Country (2027-2032) & (USD/unit) Table 137. United States Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 138. Canada Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 139. Mexico Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 140. Europe Neurovascular Interventional Devices Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Neurovascular Interventional Devices Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 143. Europe Neurovascular Interventional Devices Sales by Type (2027-2032) & (k units) Table 144. Europe Neurovascular Interventional Devices Sales Price by Type (2021-2026) & (USD/unit) Table 145. Europe Neurovascular Interventional Devices Sales Price by Type (2027-2032) & (USD/unit) Table 146. Europe Neurovascular Interventional Devices Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Neurovascular Interventional Devices Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 149. Europe Neurovascular Interventional Devices Sales by Application (2027-2032) & (k units) Table 150. Europe Neurovascular Interventional Devices Sales Price by Application (2021-2026) & (USD/unit) Table 151. Europe Neurovascular Interventional Devices Sales Price by Application (2027-2032) & (USD/unit) Table 152. Europe Neurovascular Interventional Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Neurovascular Interventional Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Europe Neurovascular Interventional Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Europe Neurovascular Interventional Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 156. Europe Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 157. Europe Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units) Table 158. Europe Neurovascular Interventional Devices Sales Price by Country (2021-2026) & (USD/unit) Table 159. Europe Neurovascular Interventional Devices Sales Price by Country (2027-2032) & (USD/unit) Table 160. Germany Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 161. France Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 162. U.K. Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 163. Italy Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 164. Russia Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 165. Spain Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 166. Netherlands Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 167. Switzerland Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 168. Sweden Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 169. Poland Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 170. China Neurovascular Interventional Devices Revenue by Type (2021-2026) & (US$ Million) Table 171. China Neurovascular Interventional Devices Revenue by Type (2027-2032) & (US$ Million) Table 172. China Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 173. China Neurovascular Interventional Devices Sales by Type (2027-2032) & (k units) Table 174. China Neurovascular Interventional Devices Sales Price by Type (2021-2026) & (USD/unit) Table 175. China Neurovascular Interventional Devices Sales Price by Type (2027-2032) & (USD/unit) Table 176. China Neurovascular Interventional Devices Revenue by Application (2021-2026) & (US$ Million) Table 177. China Neurovascular Interventional Devices Revenue by Application (2027-2032) & (US$ Million) Table 178. China Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 179. China Neurovascular Interventional Devices Sales by Application (2027-2032) & (k units) Table 180. China Neurovascular Interventional Devices Sales Price by Application (2021-2026) & (USD/unit) Table 181. China Neurovascular Interventional Devices Sales Price by Application (2027-2032) & (USD/unit) Table 182. Asia Neurovascular Interventional Devices Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Neurovascular Interventional Devices Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 185. Asia Neurovascular Interventional Devices Sales by Type (2027-2032) & (k units) Table 186. Asia Neurovascular Interventional Devices Sales Price by Type (2021-2026) & (USD/unit) Table 187. Asia Neurovascular Interventional Devices Sales Price by Type (2027-2032) & (USD/unit) Table 188. Asia Neurovascular Interventional Devices Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Neurovascular Interventional Devices Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 191. Asia Neurovascular Interventional Devices Sales by Application (2027-2032) & (k units) Table 192. Asia Neurovascular Interventional Devices Sales Price by Application (2021-2026) & (USD/unit) Table 193. Asia Neurovascular Interventional Devices Sales Price by Application (2027-2032) & (USD/unit) Table 194. Asia Neurovascular Interventional Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Neurovascular Interventional Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Neurovascular Interventional Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Neurovascular Interventional Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 198. Asia Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 199. Asia Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units) Table 200. Asia Neurovascular Interventional Devices Sales Price by Country (2021-2026) & (USD/unit) Table 201. Asia Neurovascular Interventional Devices Sales Price by Country (2027-2032) & (USD/unit) Table 202. Japan Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 203. South Korea Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 204. India Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 205. Australia Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 206. Taiwan Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Neurovascular Interventional Devices Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Neurovascular Interventional Devices Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units) Table 211. SAMEA Neurovascular Interventional Devices Sales by Type (2027-2032) & (k units) Table 212. SAMEA Neurovascular Interventional Devices Sales Price by Type (2021-2026) & (USD/unit) Table 213. SAMEA Neurovascular Interventional Devices Sales Price by Type (2027-2032) & (USD/unit) Table 214. SAMEA Neurovascular Interventional Devices Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Neurovascular Interventional Devices Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units) Table 217. SAMEA Neurovascular Interventional Devices Sales by Application (2027-2032) & (k units) Table 218. SAMEA Neurovascular Interventional Devices Sales Price by Application (2021-2026) & (USD/unit) Table 219. SAMEA Neurovascular Interventional Devices Sales Price by Application (2027-2032) & (USD/unit) Table 220. SAMEA Neurovascular Interventional Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Neurovascular Interventional Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Neurovascular Interventional Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Neurovascular Interventional Devices Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 224. SAMEA Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units) Table 225. SAMEA Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units) Table 226. SAMEA Neurovascular Interventional Devices Sales Price by Country (2021-2026) & (USD/unit) Table 227. SAMEA Neurovascular Interventional Devices Sales Price by Country (2027-2032) & (USD/unit) Table 228. Brazil Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 229. Argentina Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 230. Chile Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 231. Colombia Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 232. Peru Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 234. Israel Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 235. UAE Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 236. Turkey Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 237. Iran Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 238. Egypt Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Neurovascular Interventional Devices Distributors List Table 242. Neurovascular Interventional Devices Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Neurovascular Interventional Devices Image Figure 2. Global Neurovascular Interventional Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurovascular Interventional Devices Market Size Share 2021 VS 2025 VS 2032 Figure 4. Embolization Coils Image Figure 5. Intrasaccular Devices Image Figure 6. Intracranial Stents Image Figure 7. Carotid Stents Image Figure 8. Flow Diverters Image Figure 9. Others Image Figure 10. Global Neurovascular Interventional Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Neurovascular Interventional Devices Market Size Share 2021 VS 2025 VS 2032 Figure 12. Ambulatory Surgical Centers Image Figure 13. Hospitals Image Figure 14. Clinics Image Figure 15. Others Image Figure 16. Global Neurovascular Interventional Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Neurovascular Interventional Devices Revenue (2021-2032) & (US$ Million) Figure 18. Global Neurovascular Interventional Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Neurovascular Interventional Devices Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Neurovascular Interventional Devices Revenue Market Share by Region (2021-2032) Figure 21. Global Neurovascular Interventional Devices Sales (2021-2032) & (k units) Figure 22. Global Neurovascular Interventional Devices Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 23. Global Neurovascular Interventional Devices Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Neurovascular Interventional Devices Sales YoY (2021-2032) & (k units) Figure 25. Europe Neurovascular Interventional Devices Sales YoY (2021-2032) & (k units) Figure 26. China Neurovascular Interventional Devices Sales YoY (2021-2032) & (k units) Figure 27. Asia (Excluding China) Neurovascular Interventional Devices Sales YoY (2021-2032) & (k units) Figure 28. South America, Middle East and Africa Neurovascular Interventional Devices Sales YoY (2021-2032) & (k units) Figure 29. Global Neurovascular Interventional Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Neurovascular Interventional Devices Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Neurovascular Interventional Devices Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Neurovascular Interventional Devices Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Neurovascular Interventional Devices Revenue Market Share by Type (2021-2032) Figure 35. Global Neurovascular Interventional Devices Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Neurovascular Interventional Devices Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Neurovascular Interventional Devices Sales Market Share by Type (2021-2032) Figure 38. Global Neurovascular Interventional Devices Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Neurovascular Interventional Devices Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Neurovascular Interventional Devices Revenue Market Share by Application (2021-2032) Figure 41. Global Neurovascular Interventional Devices Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 42. Global Neurovascular Interventional Devices Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Neurovascular Interventional Devices Sales Market Share by Application (2021-2032) Figure 44. North America Neurovascular Interventional Devices Revenue Share by Type (2021-2032) Figure 45. North America Neurovascular Interventional Devices Sales Share by Type (2021-2032) Figure 46. North America Neurovascular Interventional Devices Revenue Share by Application (2021-2032) Figure 47. North America Neurovascular Interventional Devices Sales Share by Application (2021-2032) Figure 48. North America Neurovascular Interventional Devices Revenue Share by Country (2021-2032) Figure 49. North America Neurovascular Interventional Devices Sales Share by Country (2021-2032) Figure 50. Europe Neurovascular Interventional Devices Revenue Share by Type (2021-2032) Figure 51. Europe Neurovascular Interventional Devices Sales Share by Type (2021-2032) Figure 52. Europe Neurovascular Interventional Devices Revenue Share by Application (2021-2032) Figure 53. Europe Neurovascular Interventional Devices Sales Share by Application (2021-2032) Figure 54. Europe Neurovascular Interventional Devices Revenue Share by Country (2021-2032) Figure 55. Europe Neurovascular Interventional Devices Sales Share by Country (2021-2032) Figure 56. China Neurovascular Interventional Devices Revenue Share by Type (2021-2032) Figure 57. China Neurovascular Interventional Devices Sales Share by Type (2021-2032) Figure 58. China Neurovascular Interventional Devices Revenue Share by Application (2021-2032) Figure 59. China Neurovascular Interventional Devices Sales Share by Application (2021-2032) Figure 60. Asia Neurovascular Interventional Devices Revenue Share by Type (2021-2032) Figure 61. Asia Neurovascular Interventional Devices Sales Share by Type (2021-2032) Figure 62. Asia Neurovascular Interventional Devices Revenue Share by Application (2021-2032) Figure 63. Asia Neurovascular Interventional Devices Sales Share by Application (2021-2032) Figure 64. Asia Neurovascular Interventional Devices Revenue Share by Country (2021-2032) Figure 65. Asia Neurovascular Interventional Devices Sales Share by Country (2021-2032) Figure 66. SAMEA Neurovascular Interventional Devices Revenue Share by Type (2021-2032) Figure 67. SAMEA Neurovascular Interventional Devices Sales Share by Type (2021-2032) Figure 68. SAMEA Neurovascular Interventional Devices Revenue Share by Application (2021-2032) Figure 69. SAMEA Neurovascular Interventional Devices Sales Share by Application (2021-2032) Figure 70. SAMEA Neurovascular Interventional Devices Revenue Share by Country (2021-2032) Figure 71. SAMEA Neurovascular Interventional Devices Sales Share by Country (2021-2032) Figure 72. Neurovascular Interventional Devices Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Neurovascular Interventional Devices Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Embolization Coils
  • Intrasaccular Devices
  • Intracranial Stents
  • Carotid Stents
  • Flow Diverters
  • Others
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Johnson & Johnson
  • Medtronic PLC
  • W.L. Gore & Associates
  • Terumo Corporation
  • Stryker Corporation
  • Penumbra, Inc.
  • Microport Scientific Corporation
  • Merit Medical Systems, Inc.
  • Cardinal Health
  • Boston Scientific Corporation
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neurovascular Interventional Devices Market by Type
  3. 1.2.1 Global Neurovascular Interventional Devices Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Embolization Coils
  5. 1.2.3 Intrasaccular Devices
  6. 1.2.4 Intracranial Stents
  7. 1.2.5 Carotid Stents
  8. 1.2.6 Flow Diverters
  9. 1.2.7 Others
  10. 1.3 Neurovascular Interventional Devices Market by Application
  11. 1.3.1 Global Neurovascular Interventional Devices Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Ambulatory Surgical Centers
  13. 1.3.3 Hospitals
  14. 1.3.4 Clinics
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Neurovascular Interventional Devices Market Dynamics
  1. 2.1 Neurovascular Interventional Devices Industry Trends
  2. 2.2 Neurovascular Interventional Devices Industry Drivers
  3. 2.3 Neurovascular Interventional Devices Industry Opportunities and Challenges
  4. 2.4 Neurovascular Interventional Devices Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Neurovascular Interventional Devices Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Neurovascular Interventional Devices Revenue by Region
  3. 3.2.1 Global Neurovascular Interventional Devices Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neurovascular Interventional Devices Revenue by Region (2021-2026)
  5. 3.2.3 Global Neurovascular Interventional Devices Revenue by Region (2027-2032)
  6. 3.2.4 Global Neurovascular Interventional Devices Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Neurovascular Interventional Devices Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Neurovascular Interventional Devices Sales by Region
  9. 3.4.1 Global Neurovascular Interventional Devices Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Neurovascular Interventional Devices Sales by Region (2021-2026)
  11. 3.4.3 Global Neurovascular Interventional Devices Sales by Region (2027-2032)
  12. 3.4.4 Global Neurovascular Interventional Devices Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Neurovascular Interventional Devices Revenue by Manufacturers
  2. 4.1.1 Global Neurovascular Interventional Devices Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Neurovascular Interventional Devices Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Neurovascular Interventional Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neurovascular Interventional Devices Sales by Manufacturers
  6. 4.2.1 Global Neurovascular Interventional Devices Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Neurovascular Interventional Devices Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Neurovascular Interventional Devices Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Neurovascular Interventional Devices Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Neurovascular Interventional Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Neurovascular Interventional Devices Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Neurovascular Interventional Devices Manufacturers, Product Type & Application
  13. 4.7 Global Neurovascular Interventional Devices Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Neurovascular Interventional Devices Market CR5 and HHI
  16. 4.8.2 2025 Neurovascular Interventional Devices Tier 1, Tier 2, and Tier 3
5 Neurovascular Interventional Devices Market by Type
  1. 5.1 Global Neurovascular Interventional Devices Revenue by Type
  2. 5.1.1 Global Neurovascular Interventional Devices Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Neurovascular Interventional Devices Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Neurovascular Interventional Devices Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Neurovascular Interventional Devices Sales by Type
  6. 5.2.1 Global Neurovascular Interventional Devices Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurovascular Interventional Devices Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Neurovascular Interventional Devices Sales Market Share by Type (2021-2032)
  9. 5.3 Global Neurovascular Interventional Devices Price by Type
6 Neurovascular Interventional Devices Market by Application
  1. 6.1 Global Neurovascular Interventional Devices Revenue by Application
  2. 6.1.1 Global Neurovascular Interventional Devices Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Neurovascular Interventional Devices Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Neurovascular Interventional Devices Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Neurovascular Interventional Devices Sales by Application
  6. 6.2.1 Global Neurovascular Interventional Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Neurovascular Interventional Devices Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Neurovascular Interventional Devices Sales Market Share by Application (2021-2032)
  9. 6.3 Global Neurovascular Interventional Devices Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Neurovascular Interventional Devices Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Medtronic PLC
  8. 7.2.1 Medtronic PLC Company Information
  9. 7.2.2 Medtronic PLC Business Overview
  10. 7.2.3 Medtronic PLC Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Medtronic PLC Neurovascular Interventional Devices Product Portfolio
  12. 7.2.5 Medtronic PLC Recent Developments
  13. 7.3 W.L. Gore & Associates
  14. 7.3.1 W.L. Gore & Associates Company Information
  15. 7.3.2 W.L. Gore & Associates Business Overview
  16. 7.3.3 W.L. Gore & Associates Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 W.L. Gore & Associates Neurovascular Interventional Devices Product Portfolio
  18. 7.3.5 W.L. Gore & Associates Recent Developments
  19. 7.4 Terumo Corporation
  20. 7.4.1 Terumo Corporation Company Information
  21. 7.4.2 Terumo Corporation Business Overview
  22. 7.4.3 Terumo Corporation Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Terumo Corporation Neurovascular Interventional Devices Product Portfolio
  24. 7.4.5 Terumo Corporation Recent Developments
  25. 7.5 Stryker Corporation
  26. 7.5.1 Stryker Corporation Company Information
  27. 7.5.2 Stryker Corporation Business Overview
  28. 7.5.3 Stryker Corporation Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Stryker Corporation Neurovascular Interventional Devices Product Portfolio
  30. 7.5.5 Stryker Corporation Recent Developments
  31. 7.6 Penumbra, Inc.
  32. 7.6.1 Penumbra, Inc. Company Information
  33. 7.6.2 Penumbra, Inc. Business Overview
  34. 7.6.3 Penumbra, Inc. Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Penumbra, Inc. Neurovascular Interventional Devices Product Portfolio
  36. 7.6.5 Penumbra, Inc. Recent Developments
  37. 7.7 Microport Scientific Corporation
  38. 7.7.1 Microport Scientific Corporation Company Information
  39. 7.7.2 Microport Scientific Corporation Business Overview
  40. 7.7.3 Microport Scientific Corporation Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Microport Scientific Corporation Neurovascular Interventional Devices Product Portfolio
  42. 7.7.5 Microport Scientific Corporation Recent Developments
  43. 7.8 Merit Medical Systems, Inc.
  44. 7.8.1 Merit Medical Systems, Inc. Company Information
  45. 7.8.2 Merit Medical Systems, Inc. Business Overview
  46. 7.8.3 Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Portfolio
  48. 7.8.5 Merit Medical Systems, Inc. Recent Developments
  49. 7.9 Cardinal Health
  50. 7.9.1 Cardinal Health Company Information
  51. 7.9.2 Cardinal Health Business Overview
  52. 7.9.3 Cardinal Health Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Cardinal Health Neurovascular Interventional Devices Product Portfolio
  54. 7.9.5 Cardinal Health Recent Developments
  55. 7.10 Boston Scientific Corporation
  56. 7.10.1 Boston Scientific Corporation Company Information
  57. 7.10.2 Boston Scientific Corporation Business Overview
  58. 7.10.3 Boston Scientific Corporation Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Boston Scientific Corporation Neurovascular Interventional Devices Product Portfolio
  60. 7.10.5 Boston Scientific Corporation Recent Developments
  61. 7.11 Abbott Laboratories
  62. 7.11.1 Abbott Laboratories Company Information
  63. 7.11.2 Abbott Laboratories Business Overview
  64. 7.11.3 Abbott Laboratories Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Abbott Laboratories Neurovascular Interventional Devices Product Portfolio
  66. 7.11.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America Neurovascular Interventional Devices Market Size by Type
  2. 8.1.1 North America Neurovascular Interventional Devices Revenue by Type (2021-2032)
  3. 8.1.2 North America Neurovascular Interventional Devices Sales by Type (2021-2032)
  4. 8.1.3 North America Neurovascular Interventional Devices Price by Type (2021-2032)
  5. 8.2 North America Neurovascular Interventional Devices Market Size by Application
  6. 8.2.1 North America Neurovascular Interventional Devices Revenue by Application (2021-2032)
  7. 8.2.2 North America Neurovascular Interventional Devices Sales by Application (2021-2032)
  8. 8.2.3 North America Neurovascular Interventional Devices Price by Application (2021-2032)
  9. 8.3 North America Neurovascular Interventional Devices Market Size by Country
  10. 8.3.1 North America Neurovascular Interventional Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Neurovascular Interventional Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Neurovascular Interventional Devices Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Neurovascular Interventional Devices Market Size by Type
  2. 9.1.1 Europe Neurovascular Interventional Devices Revenue by Type (2021-2032)
  3. 9.1.2 Europe Neurovascular Interventional Devices Sales by Type (2021-2032)
  4. 9.1.3 Europe Neurovascular Interventional Devices Price by Type (2021-2032)
  5. 9.2 Europe Neurovascular Interventional Devices Market Size by Application
  6. 9.2.1 Europe Neurovascular Interventional Devices Revenue by Application (2021-2032)
  7. 9.2.2 Europe Neurovascular Interventional Devices Sales by Application (2021-2032)
  8. 9.2.3 Europe Neurovascular Interventional Devices Price by Application (2021-2032)
  9. 9.3 Europe Neurovascular Interventional Devices Market Size by Country
  10. 9.3.1 Europe Neurovascular Interventional Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Neurovascular Interventional Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Neurovascular Interventional Devices Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Neurovascular Interventional Devices Market Size by Type
  2. 10.1.1 China Neurovascular Interventional Devices Revenue by Type (2021-2032)
  3. 10.1.2 China Neurovascular Interventional Devices Sales by Type (2021-2032)
  4. 10.1.3 China Neurovascular Interventional Devices Price by Type (2021-2032)
  5. 10.2 China Neurovascular Interventional Devices Market Size by Application
  6. 10.2.1 China Neurovascular Interventional Devices Revenue by Application (2021-2032)
  7. 10.2.2 China Neurovascular Interventional Devices Sales by Application (2021-2032)
  8. 10.2.3 China Neurovascular Interventional Devices Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neurovascular Interventional Devices Market Size by Type
  2. 11.1.1 Asia Neurovascular Interventional Devices Revenue by Type (2021-2032)
  3. 11.1.2 Asia Neurovascular Interventional Devices Sales by Type (2021-2032)
  4. 11.1.3 Asia Neurovascular Interventional Devices Price by Type (2021-2032)
  5. 11.2 Asia Neurovascular Interventional Devices Market Size by Application
  6. 11.2.1 Asia Neurovascular Interventional Devices Revenue by Application (2021-2032)
  7. 11.2.2 Asia Neurovascular Interventional Devices Sales by Application (2021-2032)
  8. 11.2.3 Asia Neurovascular Interventional Devices Price by Application (2021-2032)
  9. 11.3 Asia Neurovascular Interventional Devices Market Size by Country
  10. 11.3.1 Asia Neurovascular Interventional Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Neurovascular Interventional Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Neurovascular Interventional Devices Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neurovascular Interventional Devices Market Size by Type
  2. 12.1.1 SAMEA Neurovascular Interventional Devices Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Neurovascular Interventional Devices Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Neurovascular Interventional Devices Price by Type (2021-2032)
  5. 12.2 SAMEA Neurovascular Interventional Devices Market Size by Application
  6. 12.2.1 SAMEA Neurovascular Interventional Devices Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Neurovascular Interventional Devices Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Neurovascular Interventional Devices Price by Application (2021-2032)
  9. 12.3 SAMEA Neurovascular Interventional Devices Market Size by Country
  10. 12.3.1 SAMEA Neurovascular Interventional Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Neurovascular Interventional Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Neurovascular Interventional Devices Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Neurovascular Interventional Devices Value Chain Analysis
  2. 13.1.1 Neurovascular Interventional Devices Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Neurovascular Interventional Devices Production Mode & Process
  6. 13.2 Neurovascular Interventional Devices Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Neurovascular Interventional Devices Distributors
  9. 13.2.3 Neurovascular Interventional Devices Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst